朗坤科技 reported revenue of ¥1.04B for the period ended 2026-06-30, +21.8% year on year. Net income was ¥0.20B, a 18.8% net margin on a 35.7% gross margin. The largest revenue line is 生物能源 at 43% of the total. Free cash flow for the period was ¥-0.05B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥1.04B | +21.8% |
| Gross profit | ¥0.37B | — |
| Operating income | ¥0.23B | — |
| Net income | ¥0.20B | +28.8% |
| Gross margin | 35.7% | Net margin 18.8% |
| Revenue Q/Q | +7.3% | — |
| Segment | Revenue | Share |
|---|---|---|
| 生物能源 | ¥0.45B | 43.1% |
| 运营服务 | ¥0.33B | 31.8% |
| 工程建造 | ¥0.26B | 24.8% |
| 其他(补充) | ¥0.00B | 0.3% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.67B | 64.3% |
| R&D | ¥0.03B | 3.3% |
| SG&A | ¥0.08B | 7.7% |
| Tax & other | ¥0.03B | 3.0% |
| Item | Amount |
|---|---|
| Total assets | ¥6.70B |
| Total liabilities | ¥2.64B |
| Shareholders' equity | ¥4.05B |
| Equity / assets | 60.5% |
| Operating cash flow | ¥0.10B |
| Capital expenditure | ¥0.15B |
| Free cash flow | ¥-0.05B |
| Cash conversion (OCF / net income) | 119% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
西测测试 ・ 美利信 ・ 万得凯 ・ 鑫宏业 ・ 昆船智能 ・ 智立方 ・ 凡拓数创 ・ 科瑞思 ・ 威士顿 ・ 慧博云通 ・ 鑫磊股份 ・ 维海德
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies